参考文献/References:
[1] Zijlstra JM,Lindauer-van der Werf G,Hoekstra OS,et al.18F-fluoro-deoxyglucose positron emission tomography for post-treatment evaluation of malignant lymphoma:a systematic review.Haematologica,2006,91(4):522-529.
[2] Terasawa T,Nihashi T,Hotta T,et al.18F-FDG PET for posttherapy assessment of Hodgkin’s disease and aggressive Non-Hodgkin’s lymphoma:a systematic review.J Nucl Med,2008,49(1):13-21.
[3] Juweid ME,Wiseman GA,Vose JM,et al.Response assessment of aggressive non-Hodgkin’s lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography.J Clin Oncol,2005,23(21):4652-4661.
[4] Picardi M,De Renzo A,Pane F,et al.Randomized comparison of consolidation radiation versus observation in bulky Hodgkin’s lymphoma with post-chemotherapy negative positron emission tomography scans.Leuk Lymphoma,2007,48(9):1721-1727.
[5] Mikhaeel NG,Hutchings M,Fields PA,et al.FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma.Ann Oncol,2005,16(9):1514-1523.
[6] Spaepen K,Stroobants S,Dupont P,et al.Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin’s lymphoma.Ann Oncol,2002,13(9):1356-1363.
[7] Hutchings M,Loft A,Hansen M,et al.FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma.Blood,2006,107(1):52-59.
[8] Mikhaeel NG.Interim fluorodeoxyglucose positron emission tomography for early response assessment in diffuse large B cell lymphoma:where are we now?.Leuk Lymphoma,2009,50(12):1931-1936.
[9] Terasawa T,Dahabreh U,Nihashi T.Fluorine-18-fluorodeoxyglucose positron emission tomography in response assessment before high-dose chemotherapy for lymphoma:a systematic review and meta-analysis.Oncologist,2010,15(7):750-759.
[10] Lin C,Itti E,Haioun C,et al.Early 18F-FDC PET for prediction of prognosis in patients with diffuse large B-cell lymphoma:SUV-based assessment versus visual analysis.J Nucl Med,2007,48(10):1626-1632.
[11] Torizuka T,Nakamura F,Kanno T,et al.Early therapy monitoring with FDG-FET in aggressive non-Hodgkin’s lymphoma and Hodgkin’s lymphoma.Eur J Nucl Med Mol Imaging,2004,31(1):22-28.
[12] Itti E,Juweid ME,Haioun C,et al.Improvement of early 18F-FDG PET interpretation in diffuse large B-cell lymphoma:importance of the reference background.J Nucl Med,2010,51(12):1857-1862.
[13] Crocchiolo R,Canevari C,Assanelli A,et al.Pre-transplant 18FDG-PET predicts outcome in lymphoma patients treated with high-dose sequential chemotherapy followed by autologous stem cell trans-plantation.Leuk Lymphoma,2008,49(4):727-733.
相似文献/References:
[1]岳进,苏丽萍.全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用[J].国际放射医学核医学杂志,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
Yue Jin,Su Lipin.Function of whole-body MRI and PET/CT in the diagnosis and prognosis of lymphoma with bone marrow infiltration[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
[2]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[3]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[4]李菲,黄俊星,张俊.18F-FDG PET/CT在食管癌中的临床应用[J].国际放射医学核医学杂志,2016,40(4):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
Li Fei,Huang Junxing,Zhang Jun.The clinical application of 18F-FDG PET/CT in esophageal cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
[5]许靖,李肖红,秦永德,等.帕金森病脑部葡萄糖代谢和脑多巴胺转运体PET显像特点的临床研究[J].国际放射医学核医学杂志,2016,40(5):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
Xu Jing,Li Xiaohong,Qin Yongde,et al.Clinical study of brain glucose metabolism and brain dopamine transporter PET imaging in patients with Parkinson’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
[6]曹登敏,林美福,陈文新,等.继发性骨淋巴瘤的18F-FDG PET/CT影像学表现[J].国际放射医学核医学杂志,2016,40(6):403.[doi:10.3760/cma.j.issn.1673-4114.2016.06.001]
Cao Dengmin,Lin Meifu,Chen Wenxin,et al.Analysis on 18F-FDG PET/CT imaging characteristics in secondary bone lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):403.[doi:10.3760/cma.j.issn.1673-4114.2016.06.001]
[7]李生栩,唐明灯,林端瑜,等.18F-FDG PET/CT在胸段食管鳞癌淋巴结转移中的诊断价值[J].国际放射医学核医学杂志,2016,40(6):408.[doi:10.3760/cma.j.issn.1673-4114.2016.06.002]
Li Shengxu,Tang Mingdeng,Lin Duanyu,et al.Value of 18F-FDG PET/CT in detecting metastatic lymph nodes of thoracic esophageal squamous cell carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):408.[doi:10.3760/cma.j.issn.1673-4114.2016.06.002]
[8]张莹莹,王振光,武凤玉,等.特发性肺间质纤维化HRCT病变区与非病变区18F-FDG PET/CT表现分析[J].国际放射医学核医学杂志,2016,40(6):414.[doi:10.3760/cma.j.issn.1673-4114.2016.06.003]
Zhang Yingying,Wang Zhenguang,Wu Fengyu,et al.18F-FDG PET/CT imaging analysis of regions with abnormal and normal pulmonary parenchyma on high resolution CT in idiopathic pulmonary fibrosis patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):414.[doi:10.3760/cma.j.issn.1673-4114.2016.06.003]
[9]张毓艺,姚稚明.18F-FDG PET/CT对非小细胞肺癌淋巴结分期诊断价值的研究进展[J].国际放射医学核医学杂志,2016,40(6):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
Zhang Yuyi,Yao Zhiming.The progress of 18F-FDG PET/CT in the diagnosis of N-staging of non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
[10]郝新忠,武志芳,武萍,等.SAPHO综合征18F-FDG PET/CT显像和临床分析[J].国际放射医学核医学杂志,2015,39(6):447.[doi:10.3760/cma.j.issn.1673-4114.2015.06.003]
Hao Xinzhong,Wu Zhifang,Wu Ping,et al.18F-FDG PET/CT imaging and clinical features of SAPHO syndrome[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):447.[doi:10.3760/cma.j.issn.1673-4114.2015.06.003]
[11]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[12]萨日,赵红光,关锋,等.18F-FDG PET/CT在弥漫性大B细胞淋巴瘤疗效评价中的临床价值[J].国际放射医学核医学杂志,2013,37(1):9.[doi:10.3760/cma.j.issn.1673-4114.2013.01.003]
SA Ri,ZHAO Hong-guang,GUAN Feng,et al.Clinical value of 18F-FDG PET/CT in evaluation of curative effect on diffuse large B cell lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(4):9.[doi:10.3760/cma.j.issn.1673-4114.2013.01.003]
[13]郑玉民,颜珏.18F-氟脱氧葡萄糖PET在恶性淋巴瘤中的应用[J].国际放射医学核医学杂志,2008,32(6):347.
ZHENG Yu-min,YAN Jue.The role of 18F-fluorodeoxyglucoxe PET in malignant lymphomas[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(4):347.
[14]张悦,高硕.18F-氟脱氧葡萄糖PET在淋巴瘤中的应用价值[J].国际放射医学核医学杂志,2007,31(5):292.
ZHANG Yue,GAO Shuo.The value of 18F-fluorodeoxyglucose PET in lymphomas[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(4):292.
[15]赵德善,乔振华.18F-氟脱氧葡萄糖PET-CT在淋巴瘤中的应用价值[J].国际放射医学核医学杂志,2007,31(3):141.
ZHAO De-shan,QIAO Zhen-hua.The clinical value of 18F-fluorodeoxyglucose PET-CT in lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(4):141.
[16]段钰,邓小虎,徐迟峰,等.面部原发性外周T细胞淋巴瘤-非特指型18F-FDG PET/CT显像一例[J].国际放射医学核医学杂志,2017,41(6):455.[doi:10.3760/cma.j.issn.1673-4114.2017.06.014]
[17]周夜夜,邓胜明,章斌,等.18F-FDG PET/CT在儿童及青少年淋巴瘤诊治中的应用价值[J].国际放射医学核医学杂志,2018,(6):535.[doi:10.3760/cma.j.issn.1673-4114.2018.06.011]
Zhou Yeye,Deng Shengming,Zhang Bin,et al.Value of 18F-FDG PET/CT for diagnosing and treating childhood and adolescent lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(4):535.[doi:10.3760/cma.j.issn.1673-4114.2018.06.011]